Natalex

What Natalex does

Natalex S.A. is a Warsaw, Poland-based fine chemicals manufacturer founded in 1980 and organized as a Polish public joint-stock company (S.A.) with registered share capital of 3,000,000 PLN. The company employs over 50 people and operates as a small, family-run business serving primarily the pharmaceutical industry, with secondary exposure to broader specialty chemical buyers. Its core offering is the custom synthesis of advanced intermediates under confidentiality agreements, ranging from laboratory trials to production-scale quantities, complemented by a catalog of 169+ standard fine chemicals. Manufacturing relies on a specialized reaction toolkit covering bromination, chlorination, esterification, nitration, oxidation, reduction, sulfonation, and ketene processing.

Revenue is generated through two streams: (i) one-off and ongoing sales of catalog fine chemicals / pharmaceutical intermediates, and (ii) custom synthesis services delivered under exclusivity / confidentiality contracts. The go-to-market is sales-led and direct, with customer inquiries handled via dedicated product and general enquiry email addresses ([email protected]; [email protected]). Distribution is from a single Warsaw site on ul. Fleminga 2A, positioned centrally in Europe with road-freight reach across the continent and air-freight access via Warsaw airport for global shipments of sensitive chemicals. Marketing is not channeled through digital or social platforms per the available data.

The company has historically supplemented its own capex with EU structural funds from the Mazovia Regional Operational Programme (2007–2013), underwriting an innovative-equipment project in 2010 (~907,562 PLN EU contribution on a ~6.23M PLN total project) and a 2012 environmental/BAT-compliance project (~2.67M PLN EU contribution on a ~6.57M PLN total project). Ownership is concentrated among family and private shareholders, with no institutional, private equity, or parent-company ownership disclosed. Most recent documented activity is a 2020 series of shareholder communications mandating share certificate dematerialisation under Poland's amended Commercial Companies Code.

Name

Natalex

Legal name

Natalex S.A.

Website

https://natalex.com.pl

Company type

Public

Founded year

1980

Operating status

Operating

Headcount range

11–50 employees

Short description

Natalex S.A. is a small, family-run Polish fine chemicals manufacturer founded in 1980, producing a 169+ product catalog of pharmaceutical intermediates and offering custom synthesis under confidentiality to pharma and specialty chemical buyers in Europe.

Ownership category

akta.pro rank

Product category

Fine Chemicals Manufacturing

NAICS

All Other Basic Organic Chemical Manufacturing (325199)

SIC

Industrial Organic Chemicals (2860), Medicinal Chemicals & Botanical Products (2833)

akta.pro industry

PRIMARYIMAEABAD

Electronic & High-Purity Specialty Chemicals

Industrials, Manufacturing & Construction/Chemicals & Industrial Materials/Specialty Chemicals

Keywords

• Fine chemicals manufacturing
• Pharmaceutical intermediates
• Custom chemical synthesis
• Specialty organic chemicals
• Chemical reaction services

Headquarters

HQ city

Warsaw

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Fine Chemical Manufacturing: Manufacturing and sale of standard fine chemicals and pharmaceutical intermediates from an extensive product portfolio of 169+ products. Revenue generated through product sales with both one-time orders and ongoing supply relationships.
2. Custom Synthesis Services: Custom synthesis of advanced intermediates under confidentiality agreements, ranging from initial laboratory trials to full-scale production quantities. Offers exclusive manufacturing arrangements for certain products.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Natalex manufactures fine chemicals, predominantly pharmaceutical intermediates and specialty organic compounds, from its Warsaw facility. The company sells a catalog of 169+ standard chemical products (including chiral intermediates, pyrimidine derivatives, brominated compounds, and other fine chemicals) and offers custom synthesis services under confidentiality agreements, scaling from laboratory trials through full production quantities.

Product overview

Natalex is a fine chemicals manufacturer established in 1980, specializing in producing chemical intermediates and specialty chemicals predominantly for the pharmaceutical industry. The company offers a portfolio of standard chemical products including over 160 compounds such as N-acetyl-(L)-phenylalanine, azobenzene, camphorquinone isomers, and various pyrimidine derivatives. In addition to standard products, Natalex provides custom synthesis services under confidentiality agreements, enabling production from laboratory trials to large-scale manufacturing. The company employs specialized chemical reactions including bromination, chlorination, esterification, nitration, oxidation, reduction, sulfonation, and ketene processing.

Differentiator

Problem solved

Functional benefit

Products and services

• Standard Fine Chemicals Catalog A catalog of 169+ standard fine chemicals and pharmaceutical intermediates (including chiral intermediates such as N-acetyl-(L)-phenylalanine and camphorquinone isomers, halogenated pyrimidines, propiolate esters, brominated alcohols, and other specialty organic compounds) sold directly from Natalex's Warsaw manufacturing facility to pharmaceutical and specialty chemical buyers.
• Custom Synthesis Services Bespoke synthesis of advanced intermediates and proprietary chemistries for pharmaceutical and specialty chemical customers, executed under full confidentiality agreements and scaled from initial laboratory trials through full production-scale quantities, with exclusive manufacturing arrangements available for certain products.

Quantifiable outcome

• Over 20 years of continuous delivery service to most loyal customers

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators4 records

Recent moves3 records

Expansion highlights3 records

Direct peers

• Hovione: Portuguese-headquartered CDMO specializing in custom synthesis of pharmaceutical intermediates and APIs with full confidentiality arrangements. Highly comparable to Natalex's custom-synthesis, pharma-focused fine chemicals model, although Hovione operates at significantly larger scale.
• EUROAPI: French API and intermediates manufacturer spun off from Sanofi, focused on complex small-molecule synthesis for the pharmaceutical industry. Directly comparable to Natalex's fine chemicals and pharma intermediates offering, though at much greater scale and with broader API capabilities.
• Sterling Pharma Solutions: UK-based CDMO offering custom synthesis and contract manufacturing of fine chemicals and APIs from laboratory to commercial scale. Comparable to Natalex's confidentiality-driven, custom-intermediates model for pharmaceutical customers.
• PCAS (Seqens): French specialty chemicals and pharmaceutical intermediates manufacturer, now part of Seqens, with a portfolio similar to Natalex in complex organic synthesis serving pharma and specialty markets. Closely comparable in product mix and customer focus.
• Cambrex: US-based CDMO specializing in small-molecule APIs and pharmaceutical intermediates via custom synthesis and contract manufacturing. Comparable to Natalex's specialized reaction platform and pharma intermediate focus, though at substantially larger scale.
• AMRI (Curia): Global CDMO providing custom synthesis, API manufacturing, and pharmaceutical intermediates to drug developers. Comparable to Natalex in custom fine chemicals and intermediates serving pharma customers, with broader service scope.
• PolyPeptide Laboratories: Swiss-headquartered CDMO offering custom peptide and small-molecule synthesis for pharmaceutical applications. Comparable to Natalex's custom-synthesis, confidentiality-driven pharma intermediates model, though focused on peptides.

Broad incumbents

• Siegfried Holding: Swiss pharmaceutical CDMO offering API and intermediates manufacturing across the full lifecycle. Operates broadly in the same space as Natalex but at much larger scale and with integrated services beyond custom synthesis.
• Lonza Group: Global Swiss CDMO leader across APIs, intermediates, and fine chemicals with broad pharma industry coverage. Comparable in chemistry scope to Natalex but vastly larger, with integrated development and commercial-scale capabilities.
• Johnson Matthey: UK-headquartered specialty chemicals company with a pharmaceutical materials and fine chemicals business serving API manufacturers. Comparable in fine chemical reaction capabilities to Natalex but operating across multiple end-markets at enterprise scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/natalex-s-a-

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Natalex